Hyaluronate binding and CD44 expression in human glioblastoma cells and astrocytes

Experimental Cell Research

Volumn 203, Issue 1, 1992, Pages 80-90

  Asher, Richard ^a,b   Bignami, Amico ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOMYCES;

CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; HEPARAN SULFATE; HYALURONIC ACID; MONOCLONAL ANTIBODY;

ARTICLE; ASTROCYTE; BINDING AFFINITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FETUS; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING;

ANTIBODIES, MONOCLONAL; ASTROCYTES; BINDING SITES; BRAIN; CELL LINE; CELLS, CULTURED; FETUS; FLUORESCENT ANTIBODY TECHNIQUE; GLIOMA; HUMAN; HYALURONIC ACID; RECEPTORS, LYMPHOCYTE HOMING; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0026438940     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-4827(92)90042-7     Document Type: Article

References (43)

1. The hyaluronate receptor is identical to a glycoprotein of Mr 85,000 (gp85) as shown by a monoclonal antibody that interferes with binding activity.
2. Interleukin-1β induction of tumor necrosis factor-alpha gene expression in human astroglioma cells